Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy

Lung Cancer

Volumn 16, Issue 2-3, 1997, Pages 203-213

  Ornadel, D ^a,d   Duchesne, G ^b   Wall, P ^b   Ng, A ^c   Hetzel, M ^a  

^a Middlesex and Whittington Hospitals ^*  (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

brachytherapy; endobronchial recurrence; laser resection; lung cancer; palliation

Indexed keywords

ARTICLE; BRACHYTHERAPY; BRONCHUS; CLINICAL TRIAL; HUMAN; LASER SURGERY; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEMOPTYSIS; HUMANS; LASER SURGERY; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0030988301     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(96)00630-7     Document Type: Article

References (24)

1. Medical Research Council. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer 1991; 63: 265-270.
2. Medical Research Council. A MRC randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. Br J Cancer 1992; 65: 934-941.
3. Aygun C, Weiner S, Scariato A et al. Treatment of non small cell lung cancer with external beam radiotherapy and high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1992; 23: 127-132.
4. Bedwinek J, Petty A, Bruton C et al. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1992; 22: 23-30.
5. Burt PA, O'Driscoll BR, Notley HM et al. Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron. Thorax 1990; 45: 765-768.
6. Chang L L, Horvath J, Peyton W, Ling S. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Int J Radiat Oncol Biol Phys 1994; 28: 589-596.
7. Ciezki J, Macklis RM. The palliative role of radiotherapy in the management of the cancer patient. Semin Oncol 1995; 22: 82-90.
8. Gauwitz M, Ellerbroek N, Komaki R et al. High dose endobronchial rradiation in recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1992; 23: 397-400.
9. George PJ, Garrett CP, Hetzel MR. Role of the neodymium YAG laser in the management of tracheal tumours [published erratum appears in Thorax 1987; 42: 640]. Thorax 1987; 42: 440-444.
10. George PJ, Garrett CP, Nixon C et al. Laser treatment for tracheobronchial tumours: local or general anaesthesia? Thorax 1987; 42: 656-660.
11. Gollins SW, Burt PA, Barber PV, Stout R. High dose rate intraluminal radiotherapy for carcinoma of the bronchus: outcome of treatment of 406 patients. Radiother Oncol 1994; 33: 31-40.
12. Gollins SW, Ryder WDJ, Burt PA et al. Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 1996; 39: 105-116.
13. Hetzel MR, Millard FJ, Ayesh R et al. Laser treatment for carcinoma of the bronchus. Br Med J Clin Res Ed 1983; 286: 12-16.
14. Huber RM, Fischer R, Hautmann H et al. Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules. Chest 1995; 107: 463-470.
15. Khanavkar B, Stern P, Alberti W, Nakhosteen JA. Complications associated with brachytherapy alone or with laser in lung cancer. Chest 1991; 99: 1062-1065.
16. Nori D, Allison R. Kaplan B. Samala E, Osian A, Karbowitz S. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results. Chest 1993; 104: 1006-1011.
17. Lo TC, Beamis JF, Jr, Weinstein RS et al. Intraluminal low-dose rate brachytherapy for malignant endobronchial obstruction. Radiother Oncol 1992; 23: 16-20.
18. Macha HN, Wahlers B, Reichle C, von Zwehl D. Endobronchial radiation therapy for obstructing malignancies: ten years' experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients. Lung 1995; 173: 271-280.
19. MRC Lung Cancer Working Party. Randomised controlled clinical trial of endobronchial treatment versus external beam radiotherapy in the management of endotracheal or endobronchial obstruction by lung cancer (LU18).
20. Raju PI, Roy T, McDonald RD et al. IR-192. low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction. Int J Radiat Oncol Biol Phys 1993; 27: 677-680.
21. Seagren SL, Harrell JH, Horn RA. High dose rate intraluminal irradiation in recurrent endobronchial carcinoma. Chest 1985; 88: 810-814.
22. Suh JH, Dass KK, Pagliaccio L et al. Endobronchial radiation therapy with or without neodymium yttrium aluminium garnet laser resection for managing malignant airway obstruction. Cancer 1994; 73: 2583-2588.
23. Sutedja G, Baris G, Schaake Koning C, van Zandwijk N. High dose rate brachytherapy in patients with local recurrences after radiotherapy of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992; 24: 551-553.
24. Toty L, Personne C, Colchen A, Vourc'h G. Bronchoscopic management of tracheal lesions using the neodynium yttrium aluminium garnet laser. Thorax 1981; 36: 175-178.